Gentian Diagnostics ASA
OSE:GENT
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
42
64.8
|
| Price Target |
|
We'll email you a reminder when the closing price reaches NOK.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| NO |
G
|
Gentian Diagnostics ASA
OSE:GENT
|
906.8m NOK |
Loading...
|
|
| JP |
|
Hoya Corp
TSE:7741
|
8.5T JPY |
Loading...
|
|
| CH |
|
Alcon AG
SIX:ALC
|
31.7B CHF |
Loading...
|
|
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
34.9B USD |
Loading...
|
|
| DK |
|
Coloplast A/S
CSE:COLO B
|
123.7B DKK |
Loading...
|
|
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
12.1B USD |
Loading...
|
|
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
44.6B CNY |
Loading...
|
|
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.8B GBP |
Loading...
|
|
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
6.1B USD |
Loading...
|
|
| CH |
|
Ypsomed Holding AG
SIX:YPSN
|
4.5B CHF |
Loading...
|
|
| US |
|
Merit Medical Systems Inc
NASDAQ:MMSI
|
4.8B USD |
Loading...
|
Market Distribution
| Min | -3 055 100% |
| 30th Percentile | -3.7% |
| Median | 1.8% |
| 70th Percentile | 6.8% |
| Max | 784.1% |
Other Profitability Ratios
Gentian Diagnostics ASA
Glance View
Gentian Diagnostics ASA is a medical diagnostics company. The company is headquartered in Moss, Ostfold. The company went IPO on 2016-12-14. The firm develops and manufactures in vitro diagnostic (IVD) products for the detection and quantification of specific markers for use on a wide range of clinical chemistry analysers. The Company’s product portfolio comprises turbidimetric fecal calprotectin immunoassay, which is to be run on clinical chemistry analysers: The Gentian Calprotectin Immunoassay, Cystatin C, NT-proBNP - Pre-launch, SARS-CoV-2 Ab Pre-Launch, Canine CRP and Beckman Coulter Customers. The firm is based in Moss, Norway, serving the global human and veterinary diagnostics markets through sales and representative offices in Sweden, USA and China.
See Also
Operating Margin is calculated by dividing the Operating Income by the Revenue.
The current Operating Margin for Gentian Diagnostics ASA is 13.4%, which is above its 3-year median of -1.8%.
Over the last 3 years, Gentian Diagnostics ASA’s Operating Margin has increased from -29.8% to 13.4%. During this period, it reached a low of -29.8% on Sep 30, 2022 and a high of 15.7% on Mar 31, 2025.